STOCK TITAN
  1. Home
  2. Sec-filings
  3. GNLX
  4. [ARS] Genelux Corporation SEC Filing

[ARS] Genelux Corporation SEC Filing

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - Genelux Corporation

ARS Filing - Genelux Corporation

This filing is available as a PDF document.

Filing Type: ARS

Company: Genelux Corporation (GNLX)

Acceptance Date: 2025-07-11T08:10:38.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock GNLX logo
Genelux Corp

NASDAQ:GNLX

GNLX Rankings

#4539 Ranked by Market Cap
N/A Ranked by Dividends

GNLX Latest News

Sep 2, 2025
Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference
Aug 7, 2025
Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates
Jul 7, 2025
Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development
May 6, 2025
Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates
May 1, 2025
Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference

GNLX Latest SEC Filings

Sep 3, 2025
[Form 4] Genelux Corporation Insider Trading Activity
Sep 3, 2025
[Form 4] Genelux Corporation Insider Trading Activity
Sep 3, 2025
[Form 4] Genelux Corporation Insider Trading Activity
Sep 3, 2025
[Form 4] Genelux Corporation Insider Trading Activity
Sep 3, 2025
[8-K] Genelux Corporation Reports Material Event

GNLX Stock Data

131.45M
32.78M
11.4%
19.46%
5.57%
Biotechnology
Pharmaceutical Preparations
Link
United States
WESTLAKE VILLAGE